НовостиBenzingaUBS Maintains Buy on Medline, Lowers Price Target to $43 UBS Maintains Buy on Medline, Lowers Price Target to $43 Benzinga 2026.09.25 16:15 (GMT+0) Открыть на Benzinga Другие новости